Evidence map›Paper›PMID 27717176›Full record

ArticleAdvanced healthcare materials2016

Local Delivery of PHD2 siRNA from ROS-Degradable Scaffolds to Promote Diabetic Wound Healing.

John R Martin, Christopher E Nelson, Mukesh K Gupta, Fang Yu, Samantha M Sarett, Kyle M Hocking, Alonda C Pollins, Lillian B Nanney, Jeffrey M Davidson, Scott A Guelcher and 1 more

Open access · greenAbstract read
In one paragraph

Article in Advanced healthcare materials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Gene therapy to enhance angiogenesis in chronic wounds.Molecular therapy. Nucleic acids · 2022
    Review
  6. Macrophages as a therapeutic target to promote diabetic wound healing.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. In situ sprayed NIR-responsive, analgesic black phosphorus-based gel for diabetic ulcer treatment.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

John R MartinDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Christopher E NelsonDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Mukesh K GuptaDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Fang YuDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Samantha M SarettDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Kyle M HockingDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Alonda C PollinsDepartment of Plastic Surgery, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Lillian B NanneyDepartment of Plastic Surgery, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Jeffrey M DavidsonDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Scott A GuelcherDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Craig L DuvallDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Vanderbilt University · USVanderbilt University Medical Center · USVA Tennessee Valley Healthcare System · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Substrate Mediated siRNA Delivery from Scaffolds to Promote Wound RepairR01EB019409 · NIBIB · VANDERBILT UNIVERSITY · PI Craig Lewis Duvall · 2014 to 2026
$4.0M
Integrated Training in Engineering and DiabetesT32DK101003 · NIDDK · VANDERBILT UNIVERSITY · PI Jamey D. Young · 2014 to 2026
$3.9M
Skin Regeneration with Stem Cells and ScaffoldsR01AR056138 · NIAMS · VANDERBILT UNIVERSITY · PI DAVIDSON, JEFFREY M., GUELCHER, SCOTT A · 2009 to 2013
$3.3M
Injectable Scaffold for Efficient, Tunable siRNA Delivery to Skin WoundsR21EB012750 · NIBIB · VANDERBILT UNIVERSITY · PI DUVALL, CRAIG LEWIS · 2011 to 2012
$418k
NCI NIH HHS P30 CA068485NIAMS NIH HHS R01 AR056138NIBIB NIH HHS R01 EB019409NIBIB NIH HHS R21 EB012750NIDDK NIH HHS T32 DK101003NIDDK NIH HHS U24 DK059637
6 · The paper itself

Abstract

Small interfering RNA (siRNA) delivered from reactive oxygen species-degradable tissue engineering scaffolds promotes diabetic wound healing in rats. Porous poly(thioketal-urethane) scaffolds implanted in diabetic wounds locally deliver siRNA that inhibits the expression of prolyl hydroxylase domain protein 2, thereby increasing the expression of progrowth genes and increasing vasculature, proliferating cells, and tissue development in diabetic wounds.

Indexed as

AnimalsCell ProliferationDiabetes MellitusHypoxia-Inducible Factor-Proline DioxygenasesMaleNeovascularization, PhysiologicProcollagen-Proline DioxygenaseRatsRats, Sprague-DawleyReactive Oxygen SpeciesRNA, Small InterferingTissue EngineeringTissue ScaffoldsWound HealingEgln1 protein, ratHypoxia-Inducible Factor-Proline DioxygenasesProcollagen-Proline DioxygenaseReactive Oxygen SpeciesRNA, Small Interferingdiabetesreactive oxygen speciesscaffoldssiRNAwound healing

Identifiers

PMID27717176
PMCPMC5152672
OpenAlexW2525756790

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.